
We are a patient-focused team of trailblazers dedicated to realizing the potential of microglia biology to deliver life-changing therapeutics
MANAGEMENT
OUR TEAM

BOARD OF DIRECTORS

SCIENTIFIC ADVISORY BOARD
Chairman - Marco Colonna, MD
Robert Rock Belliveau Professor of Pathology & Immunology, Washington University
John Dunlop, PhD
Chief Scientific Officer, Aliada Therapeutics
Jaime Grutzendler, MD
Dr. Harry M. Zimmerman and Dr. Nicholas and Viola Spinelli Professor of Neurology and Neuroscience; Vice-Chair for Research, Neurology; Director, Center for Experimental Neuroimaging, Yale School of Medicine
Bradley Hyman, MD, PhD
John B. Penney, Jr. Professor of Neurology, Harvard Medical School; Alzheimer’s Unit Director, MassGeneral Institute for Neurodegenerative Disease; Director, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital
Ole Isacson, MD, PhD
Professor Neurology & Neuroscience Harvard Medical School, Massachusetts General Hospital, McLean Hospital, HSCI
